The Shocking Truth Behind PACS Group's Analyst Ratings: Is This Stock a Time Bomb or a Gold Mine

Analysts' ratings for PACS Group (NYSE:PACS) over the last quarter vary from bullish to bearish, as provided by 7 analysts. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

The distribution of ratings shows that 4 analysts have a bullish stance, 3 have a somewhat bullish stance, 0 are indifferent, 0 have a somewhat bearish stance, and 0 have a bearish stance. This trend is consistent over the last 30 days, with no changes in the ratings.

Looking back at previous months, the distribution of ratings shows that 2 analysts had a bearish stance 2 months ago, 2 had a somewhat bearish stance 1 month ago, and 0 had a bearish stance 3 months ago. This indicates a shift in sentiment among analysts over time.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $40.14, a high estimate of $45.00, and a low estimate of $35.00. This upward trend is apparent, with the current average reflecting a 17.37% increase from the previous average price target of $34.20.

The average price target represents a potential upside for investors, and the increase in the average target price suggests that analysts are becoming more optimistic about PACS Group's future prospects.

An in-depth exploration of analyst ratings reveals the standing of PACS Group among financial experts. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Jason Cassorla of Citigroup announced a buy rating and set a price target of $45.00. David Macdonald of Truist Securities raised his rating to buy and set a price target of $44.00, up from $36.00. Scott Fidel of Stephens & Co. raised his rating to overweight and set a price target of $40.00, up from $37.00.

Jason Cassorla of Citigroup also raised his price target to $41.00, up from $34.00, and Michael Wiederhorn of Oppenheimer raised his rating to outperform and set a price target of $40.00, up from $32.00. David Macdonald of Truist Securities also raised his rating to buy and set a price target of $36.00, up from $32.00.

Tao Qiu of Macquarie announced an outperform rating and set a price target of $35.00. These changes in ratings and price targets suggest that analysts are becoming increasingly optimistic about PACS Group's future prospects.

Action taken by analysts is a response to changing market dynamics and the company's performance. Analysts' ratings and price targets are based on their assessment of the company's financials, management, and industry trends.

Investors should consider the analyst ratings and price targets as one factor in their investment decisions. However, it is essential to conduct thorough research and consider multiple perspectives before making any investment decisions.